Azra AI SmartPath™: Empowering Hospitals with a Proven AI-Driven Tumor Registry Management Solution

Automated Solution Ensures Seamless Cancer Reporting to NCI SEER Program Amidst Disruptions, Safeguarding Compliance and Continuity

Azra AI, a healthtech leader using artificial intelligence (AI) and workflow automation to accelerate the identification and treatment of cancer, is pleased to introduce SmartPath^™. SmartPath is an innovative AI-powered solution that offers essential support to tumor registry teams within hospitals and healthcare facilities nationwide. In light of recent disruptions in the reporting of registry data from all the states participating in the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Program, SmartPath emerges as a reliable alternative to ensure seamless operations. SmartPath streamlines the tedious and time-consuming process of casefinding and patient data abstraction, enabling healthcare professionals to focus on what matters most – providing quality patient care.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231019890043/en/

Chris Cashwell, CEO & Founder of Azra AI (Photo: Business Wire)

"We understand the immense challenges hospitals face such as staff burnout, the shortage of certified tumor registrars and razor-thin margins,” acknowledged Chris Cashwell, CEO and Founder of Azra AI. “Given the recent, unexpected disruption in reporting to the NCI SEER Program, we recognize the urgent need for a cost-effective tumor registry alternative that can be swiftly and seamlessly implemented, ensuring continuity and compliance during these trying times. Many hospitals have been negatively affected, and we stand ready to collaborate with them and any hospital looking to enhance their tumor registry workflows. Our commitment lies in going above and beyond to ensure hospitals can continue their vital operations. Empathy and readiness define our approach, and we are here to support hospitals in every way possible."

The traditional methods of identifying and reporting cancer tumors have often been plagued by manual, resource-intensive tasks, making it challenging for healthcare institutions to keep up with the increasing demands of cancer data collection and analysis. SmartPath, which is used by hospitals throughout the country, directly addresses these challenges.

Key Features of SmartPath:

• Automated Workflow: SmartPath offers a seamless, end-to-end automated workflow that significantly reduces the need for manual intervention. It effortlessly identifies and abstracts patient data, automates casefinding, and eliminates the risk of human error while ensuring accuracy in registry information.
• Efficiency and Speed: With SmartPath, hospitals can expect a remarkable increase in efficiency and speed in tumor registry operations. What previously took hours or even days can now be accomplished in a fraction of the time, allowing healthcare professionals to allocate their valuable time and resources more effectively.
• Intuitive User Interface: SmartPath boasts an intuitive and user-friendly interface that requires minimal training. Your Tumor Registry teams can quickly adapt to this state-of-the-art solution without the need for extensive IT support.
• Compliance and Reporting: Ensure compliance with regulatory requirements effortlessly with SmartPath's built-in reporting capabilities. Hospitals can automatically transmit pathology directly to state agencies as required. Generate comprehensive reports with ease, aiding in audits and quality assurance measures.
• Quick Implementation and Seamless Integration: SmartPath is easy to implement and seamlessly integrates with your existing hospital systems, including Electronic Health Records (EHR) and Health Information Management (HIM) systems. This ensures a smooth transition and minimal disruption to your existing workflows.
• Data Security: We understand the importance of patient data security. SmartPath employs robust security measures to safeguard patient information, complying with all relevant healthcare data privacy regulations.

By adopting SmartPath, hospitals can enhance the quality of cancer data collected and improve the overall patient care experience. The AI-powered automation not only reduces the burden on tumor registry teams but also supports healthcare institutions in making data-driven decisions to grow their oncology service line.

Additional Resources

• Learn more about SmartPath and how it can transform your Tumor Registry operations at www.azra-ai.com/smartpath.
• Schedule a demonstration with our experts at www.azra-ai.com/get-a-demo.
• Visit Azra AI at the Becker’s CEO + CFO Roundtable event (Nov. 13-16) and The Association of Nurse Navigation (AONN) Annual Conference (Nov. 15-19)
• Stay at the forefront of healthtech innovation and insights by following Azra AI on LinkedIn for exciting updates and thought-provoking content.

About Azra AI

Azra AI uses proprietary artificial intelligence and machine learning software to quickly identify at-risk patients in need of follow-up care, resulting in more equitable health outcomes, increased patient retention, and a reduced burden on clinical workers. This revolutionary technology — used in over 200 hospitals and cancer centers across the country — accelerates the patient care process and delivers a positive impact on clinical, financial, and operational outcomes. Learn more about Azra AI at www.azra-ai.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231019890043/en/